Cancer recurrence and the key role of the LSD1 epigenetic enzyme.

    Project: Other › Research

    Short titleCancer recurrence and the key role of the LSD1 epi
    StatusActive
    Effective start/end date29/06/16 → 29/06/19

    Funding

    • EpiAxis Therapeutics Pty Ltd: AUD337,600.00
    View all
    View less